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Effect of topically applied Saccharomyces 
boulardii on the healing of acute porcine 
wounds: a preliminary study
Jessica Partlow1, Anthony Blikslager2*, Charles Matthews3,4, Mac Law2, Joshua Daniels5, Rose Baker6 
and Raphael Labens7
Abstract 
Background: Normal wound healing progresses through a series of interdependent physiological events: inflamma-
tion, angiogenesis, re-epithelialization, granulation tissue formation and extracellular matrix remodeling. Alterations in 
this process as well as the bacterial type and load on a wound may alter the wound healing rate. The purpose of this 
study was to evaluate the effect of topical Saccharomyces boulardii on the healing of acute cutaneous wounds, using 
a prospective, controlled, experimental study, with six purpose bred landrace pigs.
Results: All wounds healed without apparent complications. Comparison of the mean 3D and 2D wound surface 
area measurements showed no significant difference between treatment groups as wounds decreased similarly in 
size over the duration of the study. A significant reduction in wound surface area was identified sooner using 3D 
assessments (by day 9) compared to 2D assessments (by day 12) (P < 0.001). There was no significant effect of treat-
ment group on the number of multiple isolates or the most common isolates obtained relative to control wounds. 
There was no histologically appreciable difference between the wounds of the different groups.
Conclusions: Topical application of Saccharomyces boulardii does not hasten wound healing or change the wounds’ 
microbiome under the conditions reported in this study.
© 2016 Partlow et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Normal wound healing progresses through a series of 
interdependent physiological events: inflammation, 
angiogenesis, re-epithelialization, granulation tissue for-
mation and extracellular matrix remodeling [1]. In the 
context of abnormal or delayed wound healing, decreased 
severity as well as duration and intensity of inflammation 
have been associated with faster healing and less scar-
ring [2]. Therefore, alterations to the levels of pro- and 
anti-inflammatory cytokines and growth factors such as 
TGF-β play an important role as they can change the rate 
of extracellular matrix destruction and wound epitheliali-
zation [3–5].
Bacterial colonization of wounds can also contribute to 
inflammation and slow the wound healing process. The 
presence of local tissue hypoxia and repetitive ischemia–
reperfusion injury, along with the alterations in MMP-9 
and TIMP levels, create conditions that promote prote-
olysis, facilitating bacterial colonization and prolongation 
of the inflammatory phase of healing [6–8]. Thus control 
of inflammation and bacterial colonization represent 
important aspects of successful wound management.
Saccharomyces boulardii is lyophilized yeast of interest 
to the authors for its antimicrobial properties and inhibi-
tory effect on pro-inflammatory cytokines in intestinal 
tissue [9–11]. The effect on pro-inflammatory cytokines 
is mediated by its action on nuclear factor κB, and mito-
gen-activated protein kinases ERK1/2 and p38 MAPK 
[12]. Its antimicrobial action and that of other yeasts is 
not well studied but has been suggested to be due to the 
secretion of hydrogen peroxide and organic acids [13], 
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the ability to competitively inhibit pathogenic bacteria 
[9, 11] and an inherent antimicrobial effect of Saccharo-
myces derived beta-glucan [14]. Given the potential for 
bacterial colonization to promote inflammation and the 
importance of inflammation in wound healing, altera-
tions to the type and degree of bacterial wound coloniza-
tion likely represent a desirable treatment approach. This 
concept is further supported by results following applica-
tion of a similar probiotic to cutaneous wounds thereby 
reducing inflammation and wound closure times [15, 16]. 
Given the aforementioned effects and positive results uti-
lizing other yeast it is conceivable that S. boulardii repre-
sents an effective wound treatment agent.
In the present study, we sought to evaluate the effect 
of topically applied S. boulardii on acute wound heal-
ing, using a relevant full thickness porcine skin wound 
model [17, 18] and previously validated 3D-imaging 
system [19]. We hypothesized that topically applied S. 
boulardii would result in no adverse events, that treated 
wounds would have a lower number of commensal and 
contaminant organisms present, that S. boulardii would 
have an effect on the histopathology of treated relative to 
non-treated healing wounds, and that S. boulardii treated 
wounds would have a shorter time to closure.
Methods
Six pigs (three intact females, three castrated males) 
aged 9  weeks and of mean weight 19.6  kg (±  1.67  kg) 
were inspected to ensure the absence of scaring on the 
dorsum. All animals were individually housed in comfort 
footing open grate pens allowing for nose-to-nose con-
tact for a total of 18 days, including 3 days of acclimation 
prior to commencement of the study. All pigs were fed 
twice daily at scheduled times with a complete grain feed 
according to age and weight. Free choice water was avail-
able at all times. Animals were videotaped and assessed 
by the authors for activity levels, response to playful stim-
uli, social interaction with the neighboring pigs and food 
intake to allow intervention if abnormal behavior indica-
tive of stress or pain was noted. The study protocol was 
approved by the North Carolina State University IACUC 
committee (reference number 12157).
At study commencement each pig had three full thick-
ness skin wounds created on their dorsum. The proce-
dures were performed under general anesthesia. Flunixin 
meglumine (1.1 mg/kg IM) and buprenorphine (0.01 mg/
kg IM) were administered pre-operatively and anesthesia 
was induced with a combination of xylazine (0.5  mg/kg 
IM) and ketamine (11 mg/kg IM). Following orotracheal 
intubation, anesthesia was maintained with 1–3.5 % iso-
flurane vaporized in 100  % oxygen. The pigs were posi-
tioned in ventral recumbency, and the dorsum of each 
pig was aseptically prepared. Three circular wounds 
measuring 4  cm in diameter, with a space of 4  cm 
between the wounds, were created on the dorsum of each 
pig with a #10 bard parker scalpel blade using a study 
template. Hemostasis was achieved with digital pressure 
and gauze sponges.
In each pig, two of the three wounds were treated 
topically with a single dose of topical S. boulardii (5 
billion live organisms, Pure Encapsulations®, Sud-
bury MA, USA) at the time of wounding. One of the 
wounds was then re-treated every 3rd day for a total of 
five treatments. The remaining third wound served as a 
control, and received no treatment. Treatment alloca-
tion was randomized using a random number genera-
tor. Following treatment, wounds were left uncovered 
and exposed to the environment. The pigs were sedated 
with xylazine (3 mg/kg IM) to facilitate treatment, vis-
ual inspection, and wound imaging every 3rd day, with 
the study end point being the conclusion of imaging 
and inspection on day 15, 3 days after the 5th and final 
wound retreatment. Wounds were imaged using a com-
mercial 3D-wound imaging system, consisting of a ded-
icated camera, associated software system and single 
use optical targets allowing automated 3D rendering of 
wound models and further processing (Eykona Medical 
US Inc., Greenville, NC, USA) (Fig.  1). Subsequently, 
similar to a previous report [20] wound margins were 
traced in generated computer models by one author 
(RB), to determine the wounds’ surface area (mm2) by 
projection of traces onto a plane surface (2D measure-
ment) or by three dimensional representation thereby 
taking the wounds’ precise topography into account 
(3D measurement).
In addition to wound imaging and visual inspection, 
sterile swabs were used to obtain samples for aerobic cul-
ture. This was performed at the time of wounding, study 
midpoint and day 15. Total number of colony forming 
units, and the five most prolific bacterial and fungal spe-
cies were identified for each wound at each time point. 
Tissue samples (5  mm diameter full thickness biopsies 
from the center and periphery of the wound) were also 
obtained for histologic evaluation at the termination 
of the study on day 15. The tissue samples were fixed 
in 10  % neutral buffered formalin, routinely processed 
using an automated tissue processor, embedded in par-
affin, sectioned at 5  μm, and stained with hematoxylin 
and eosin (H&E). The tissue sections were examined and 
graded by a board certified veterinary pathologist (ML) 
according to a 5-tiered grading scale, as follows: Grade 1, 
minimal changes from normal including edema, infiltra-
tion of inflammatory cells and overlying serum crust for-
mation, thickening of the epidermis, and accumulation 
of granulation tissue; Grade 2, mild changes as described 
above; Grade 3, moderate changes; Grade 4, moderately 
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severe changes, including some areas of necrosis of the 
epidermis; and Grade 5, severe changes including diffuse 
edema, marked inflammation, dense granulation tissue in 
the dermis, and often marked thickening of the epider-
mis with areas of epidermal necrosis. The board certified 
veterinary pathologist (ML) was blinded to the treatment 
groups.
Statistical analysis
Imaging data was analyzed using Kruskal–Wallis one-
way analyses of variance on ranks allowing individual 
comparisons between measurements (3D vs. 2D), treat-
ment groups and days. When significance was detected 
the Dunn’s method was applied to perform multiple 
comparisons versus a control group (day 0 observation). 
Two-way ANOVA was used to evaluate for any differ-
ence between the treatment and control groups in num-
ber of CFU after normal transformation of the data. To 
assess for a difference between the treatment and con-
trol groups in numbers of bacterial isolates (binned as 
either  ≤1 or  >1 Isolate) Fisher’s Exact Tests were per-
formed. For all statistical tests, completed using SigmaS-
tat® software (Systat Software, Inc., San Jose, CA, USA) 
significance was set at P ≤ 0.05.
Results
For the duration of the study, all animals remained com-
fortable and feed consumption remained constant, there 
was no alteration in activity level or social interaction. All 
wounds had healed with normal progression and con-
tracted down to a minimal surface area by day 15. There 
was no appreciable difference observed in wound appear-
ance between the treatment and control groups over 
the course of the study. Figure  1 shows examples of 3D 
wound reconstructions (a, b) alongside one of the corre-
sponding digital photographs used in rendering 3D mod-
els (c).
Comparison of the mean 3D and 2D wound surface 
area measurements showed no significant difference 
between treatment groups as wounds decreased similarly 
in size over the duration of the study. Regarding the util-
ity of 3D measurements, a significant reduction in wound 
surface area was identified sooner (by day 9) compared to 
2D assessments (by day 12) (P < 0.001) (Figs. 2, 3; Addi-
tional file 1). 
Organisms other than S. boulardii were isolated from 
all 18 wounds at all time points. There were a total of 41 
isolates from the control wounds during the study, and 
slightly lower numbers from the single (36 isolates) and 
multiply (37 isolates) treated groups. Staphylococcus hyi-
cus, Enterococcus spp., Bacillus spp., Micrococcus spp., S. 
aureus and Candida spp. were isolated from the wounds 
in this study. Staphylococcus hyicus was most commonly 
isolated (37 isolates) followed by Staphylococcus aureus 
(21 isolates), Entercoccus spp. (14 isolates) and Bacil-
lus spp. (12 isolates). There was no significant difference 
Fig. 1 Wounds created on the dorsum of Pig 2 (wound 1 treated 
every 3rd day; wound 2 was left untreated and wound 3 was treated 
once). The wounds’ 3D reconstruction is shown from above (a) and 
for wound 3 also in close-up and side view (b) on day 0 (top row) and 
at study completion (lower rows). One of three corresponding images 
used to compute each model is shown in c demonstrating the 
wounds’ truthful simulation. The circular imaging targets necessary for 
automated model computation and scaling can also be appreciated
Fig. 2 Graph of mean wound surface area for control, single and 
multiply treated wounds at each measured time point; error bars 
represent standard deviations, asterisks indicate significant differences 
from time 0 (P ≤ 0.001)
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in the number of multiple isolates (binned as either ≤1 
or  >1 isolate) or the most common isolates obtained 
between the three groups (Additional file 2).
Immediately after wound inoculation on day 0 there 
was a significantly greater number of colony forming 
units (CFU) from both treatment groups when compared 
to controls (P < 0.001) (Fig. 4). There was no significant 
difference in CFU between the three groups at mid or at 
the final time point of the study.
Table  1 shows the histological grade for each wound 
tissue sample in the study. The wound edges were each 
characterized microscopically as having a focal ulcer with 
an overlying neutrophilic crust containing small colo-
nies of cocci bacteria and groups of small to numerous 
yeasts (presumed to be the S. boulardii yeasts that were 
applied). The epidermis was moderately hyperplastic, and 
the dermis all the way to the panniculis was thickened by 
granulation tissue composed of numerous small blood 
vessels and thick collagen bundles interspersed with 
small to moderate numbers of macrophages and scat-
tered perivascular aggregates of lymphocytes and plasma 
cells (Fig. 5a, b). There were no histologically appreciable 
differences between the different animals or when com-
paring the wounds of the different groups.
Discussion
The goal of this study was to evaluate for any treat-
ment effect of topically applied S. boulardii to acute 
porcine skin wounds a model allowing wound healing 
in 12–14 days, with an epithelialization rate of approxi-
mately 0.05 mm/h [13].
As a probiotic yeast, S. boulardii was of interest for 
its antimicrobial and anti-inflammatory properties 
[9–11]. Previous studies of probiotics applied to cutane-
ous wounds have shown decreased inflammation and 
reduced time to closure [15, 16, 21]. A topically applied 
nitric oxide producing probiotic has also been shown 
to improve wound healing outcomes [22]. In contrast 
to these studies, we found no clear difference in wound 
healing outcomes when S. boulardii was applied in either 
single or multiple applications at doses of 5 billion organ-
isms. Thus we found no evidence to support the clinical 
application of S. boulardii to accelerate wound healing 
but these results should be considered cautiously in light 
of the small study population and resulting low statistical 
power. Furthermore doses of yeast included in two simi-
lar wound healing studies have been widely variable and 
it is possible the dose of S. boulardii may have been inad-
equate to exert a therapeutic effect [16] [21]. The dose of 
5 billion S. boulardii organisms was chosen to reflect the 
dose used safely in previous studies utilizing this organ-
ism [23–25].
As measurements obtained on the basis of three dimen-
sional wound imaging are associated with greater preci-
sion than conventional techniques [20] a commercial 3D 
imaging and processing system was used in this investi-
gation. Compared with a self-developed system [20], the 
authors felt that this previously validated system [19] was 
easy to operate and produced life-like 3D reconstructions 
allowing reliable clinical assessments to be made [19]. 
In addition to the technique’s superior reliability, three 
dimensional wound imaging also enables quantification 
of a wound’s topography. Disturbed wound healing may 
result in irregular and uneven wound beds; 3D imaging 
is therefore expected to be of great clinical value. Given 
Fig. 3 Graph of mean wound 3D-surface area for control, single and 
multiple treated wounds at each measured time point, error bars 
represent standard deviations, asterisks indicate significant differences 
from time 0 (P ≤ 0.001)
Fig. 4 Graph of mean CFU eluted from control, single and multiply 
treated wounds at the final time point (day 15 of study)
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that in this investigation both 2D and 3D measurements 
were equally affected by the precision of the generated 
3D model the observed difference between the 2D and 
3D assessed rate of healing is likely indicative of a change 
in wound topography prior to wound contraction occur-
ring (Figs. 2, 3). Therefore 3D surface area measurements 
are likely not only more precise but also allow detection 
of a treatment effect sooner when compared to 2D sur-
face area assessments.
The process of cutaneous wound healing involves forma-
tion of a fibrin and fibronectin matrix followed by inflam-
matory cell infiltration and wound remodeling. The wounds 
of both experimental and control groups in this study healed 
routinely with a crust of neutrophils containing small colo-
nies of cocci bacteria and a granulating wound edge con-
taining macrophages, lymphocytes and plasma cells. This 
preliminary study of the effect of Saccharomyces was per-
formed in an acute model of wound healing. In a more pro-
inflammatory state of a chronic non-healing wound there 
is an altered cytokine profile, with elevated levels of matrix 
metalloproteinases (MMPs) and reduced levels of MMP 
inhibitors along with abundant pro-inflammatory cytokines 
[6]. In such circumstances a treatment effect of S. boulardii 
might be observed and future in vitro or in vivo studies on 
models of chronic wound healing may be considered. In 
addition given the relevance of pro-inflammatory cytokines 
future work should include their quantification.
Treatment and control group wounds in our study 
cultured organisms other than S. boulardii at similar 
levels (CFU), and the wounds treated with both single 
and multiple doses of S. boulardii grew a similar popula-
tion of organisms to the control wounds. The exception 
to this being immediately after initial inoculation of the 
treated wounds with S. boulardii, which was reflected 
in the culture results. These findings indicate a lack of 
effect of S. boulardii on the wound microbiome of acute 
open wounds. These findings could also be due to the S. 
boulardii being no longer live and viable despite it being 
stored appropriately. It is also notable that this analysis 
had the highest power of the study (0.96). Future stud-
ies may evaluate for an effect of S. boulardii on models 
of grossly contaminated wounds. In such wounds, an 
elevated bacterial load and presence of potentially patho-
genic bacterial species may be positively affected by the 
previously demonstrated inhibitory effect of S. boulardii 
[10].
Wound healing investigations have often depended 
on the use of animal models, including porcine models, 
since they provide a means of studying the complex inter-
actions occurring in living tissue without some of the 
limitations and artifacts inherent to in  vitro techniques 
[26, 27]. Wounds were purposefully left uncovered allow-
ing bacterial colonization to occur to evaluate treatments 
in the context of competitive co-colonization. While it is 
more typical to cover wounds with a dressing we left the 
wounds uncovered and exposed to air so as not to alter 
the microbiome of the healing wounds [28]. The study 
size the number of wounds evaluated was appropriate 
for a preliminary study, utilizing adequate controls and 
including the randomization of treatments. This meant 
Table 1 Histopathology grading of each studied wound
Pig Wound Treatment group Histologic grade Comments
1 1 Control 3
1 2 Multiple treatments 3
1 3 Single treatment 3 Contains a focal, intense crust with numerous yeasts
2 1 Multiple treatments 3 Large areas of ulceration in these sections
2 2 Control 2 Milder inflammatory reaction in this wound
2 3 Single treatment 2
3 1 Control 3
3 2 Single treatment 3
3 3 Multiple treatments 3
4 1 Control 3
4 2 Single treatment 4
4 3 Multiple treatments 3
5 1 Single treatment 3
5 2 Multiple treatments 3
5 3 Control 3
6 1 Multiple treatments 3
6 2 Control 1
6 3 Single treatment 3
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that controls were in varying positions and distanced 
at least 4  cm from the most frequently treated wounds 
thereby rendering contamination of control wounds an 
unlikely but not impossible event. Equal numbers of male 
and female animals were chosen in an effort to prevent 
potential bias. Keeping the studies limitations in mind we 
found that single or multiple applications of S. boulardii 
did not have a treatment effect on wound measurements, 
microbiome or histology but larger numbers may be 
required to identify such an effect. Additionally, while 
quantitative wound assessments did not detect a treat-
ment effect, qualitative variables such as wound exudate, 
bleeding and color, all typically assessed by clinicians 
were not evaluated in this study. While there are some 
benefits to including qualitative measures, including a 
potentially increased ability to identify a treatment effect, 
the value and degree of scientific evidence provided by 
these evaluations is often lower and it can be difficult to 
run statistical analyses on such measures.
Conclusion
The results of this study indicate a lack of effect of S. 
boulardii applied in an acute wound-healing model. 
Our findings do not support the use of S. boulardii in a 
clinical acute wound healing environment. Future inves-
tigations may evaluate efficacy in wound healing models 
that display an altered inflammatory profile and bacterial 
microbiome and should also assess the effect of S. bou-
lardii on biomolecules relevant to the wound-healing 
environment.
Abbreviations
TGF- β: transforming growth factor β; MMP-9: metalloproteinases 9; TIMP: 
tissue inhibitor of metalloproteinase; ERK1/2: extracellular-signal-regulated 
kinases; P38 MAPK: P38 mitogen-activated protein kinases; S. boulardii: Sac-
charomyces boulardii; CFU: colony forming unit.
Authors’ contributions
JP participated in the research design, in the writing of the paper, in the 
performance of the research and participated in data analysis. AB participated 
in the research design, in the writing of the paper, in the performance of the 
research and participated in data analysis. CM participated in the research 
design. ML participated in the histopathological analysis. JD participated in 
the execution of bacterial analysis. RB participated in image acquisition and 
analysis. RL participated in the research design, in the writing of the paper, in 
the performance of the research and participated in data analysis. All authors 
read and approved the final manuscript.
Author details
1 Mid-Atlantic Equine Medical Center, Ringoes, NJ, USA. 2 College of Veterinary 
Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, 
NC 27607, USA. 3 North Carolina Comprehensive Headache Clinic, Raleigh, 
NC, USA. 4 North Carolina State University, Raleigh, NC, USA. 5 The Ohio State 
University, Columbus, OH, USA. 6 Oregon State University, College of Veterinary 
Medicine Corvallis, Corvallis, OR, USA. 7 Royal (Dick) School of Veterinary Stud-
ies and Roslin Institute, Roslin, Scotland, UK. 
Competing interests
The authors declare that they have no competing interests.
Received: 18 November 2015   Accepted: 24 March 2016
Fig. 5 a The 5 mm diameter tissue samples from the wounds’ center 
stained with hematoxylin and eosin were characterized microscopi-
cally as having a focal ulcer (ulcer not shown in this photo) with 
an overlying neutrophilic crust containing small colonies of cocci 
bacteria and numerous yeasts. In a, the epidermis is moderately 
hyperplastic and the dermis is thickened by abundant granulation 
tissue (associated with wound healing) composed of numerous 
small blood vessels and thick collagen bundles interspersed with 
small to moderate numbers of macrophages. b Higher magnifica-
tion photomicrograph showing the superficial epidermis at left and 
bottom, which is heavily infiltrated by neutrophils, most of which are 
degenerate or necrotic. At top right is a serocellular crust that contains 
degenerate neutrophils, erythrocytes, necrotic cell debris, colonies 
of bacterial cocci, and moderate numbers of yeasts, presumed to be 
Saccharomyces boulardii
Additional files
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Additional file 2. Wound microbiology.
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